Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19

Tarek Mohamed Abd El-Aziz; Ahmed Al-Sabi; James D. Stockand

doi:10.1038/s41392-020-00374-6

Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19

Tarek Mohamed Abd El-Aziz, Ahmed Al-Sabi, James D. Stockand

Department of Cellular & Integrative Physiology

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Original language	English (US)
Article number	258
Journal	Signal Transduction and Targeted Therapy
Volume	5
Issue number	1
DOIs	https://doi.org/10.1038/s41392-020-00374-6
State	Published - Dec 1 2020

ASJC Scopus subject areas

Genetics
Cancer Research

Access to Document

10.1038/s41392-020-00374-6

Cite this

@article{da2beef0c28c4fc6b58dd044ac01298a,

title = "Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19",

author = "{Abd El-Aziz}, {Tarek Mohamed} and Ahmed Al-Sabi and Stockand, {James D.}",

year = "2020",

month = dec,

day = "1",

doi = "10.1038/s41392-020-00374-6",

language = "English (US)",

volume = "5",

journal = "Signal Transduction and Targeted Therapy",

issn = "2095-9907",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19

AU - Abd El-Aziz, Tarek Mohamed

AU - Al-Sabi, Ahmed

AU - Stockand, James D.

PY - 2020/12/1

Y1 - 2020/12/1

UR - http://www.scopus.com/inward/record.url?scp=85094926463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85094926463&partnerID=8YFLogxK

U2 - 10.1038/s41392-020-00374-6

DO - 10.1038/s41392-020-00374-6

M3 - Article

C2 - 33144565

AN - SCOPUS:85094926463

SN - 2095-9907

VL - 5

JO - Signal Transduction and Targeted Therapy

JF - Signal Transduction and Targeted Therapy

IS - 1

M1 - 258

ER -

Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID­19

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19